Anuj Virmani becomes MD of JnJ MedTech India division

Published On 2023-07-25 06:11 GMT   |   Update On 2023-07-25 06:18 GMT

Mumbai: Johnson & Johnson Private Limited has announced the appointment of Anuj Virmani as the Managing Director for its Johnson & Johnson MedTech India division. With an exceptional track record of 28 years in the industry, Anuj brings extensive healthcare experience and a strategic patient-centric vision to lead the company's operations and expand reach in the tier II & III cities of the country.

With a Masters in Management Studies from BITS Pilani, Anuj has been associated with Johnson & Johnson since 1995. His extensive experience includes a stint as the Chief Financial Officer for the Middle East, Central Europe, Russia, Turkey, and Africa within the EMEA MedTech division. His expertise in General Management, Marketing, Finance, and New Business Development has fuelled successful initiatives such as developing specialties like Bariatric, Thoracic, and Colorectal, in addition to enhancing standards of care and optimizing patient pathways.

Advertisement

"His priorities as the Managing Director of Johnson & Johnson MedTech India encompass ethical leadership, nurturing talent, and reinforcing the organization’s vision of empowering 1.4 billion lives of Indians," the company stated.

Commenting on his appointment, Anuj stated, “These are exciting times for India as it transforms itself and marches to become the third-largest economy in the world. I am delighted to return to my homeland and personally witness this phenomenal journey. I look forward to collaborating with dedicated care providers, government at both central and state levels, and other key stakeholders to enhance healthcare accessibility and elevate the nation's standards of care.”

Read also: Hariharan Subramanian becomes new MD of Siemens Healthcare



Tags:    

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News